Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Consequences of JAG1 mutations.J Med Genet. 2003; 40: 891-895
- Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.Nat Genet. 1997; 16: 243-251
- Mutations in the human Jagged1 gene are responsible for Alagille syndrome.Nat Genet. 1997; 16: 235-242
- NOTCH2 mutations in Alagille syndrome.J Med Genet. 2012; 49: 138-144
- NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.Am J Hum Genet. 2006; 79: 169-173
- Diagnosis of Alagille syndrome-25 years of experience at King's college hospital.J Pediatr Gastroenterol Nutr. 2011; 52: 84-89
- Features of Alagille syndrome in 92 patients: frequency and relation to prognosis.Hepatology. 1999; 29: 822-829
- Outcome of liver disease in children with Alagille syndrome: a study of 163 patients.Gut. 2001; 49: 431-435
- A longitudinal study to identify laboratory predictors of liver disease outcome in Alagille syndrome.J Pediatr Gastroenterol Nutr. 2010; 50: 526-530
- Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy.J Pediatr. 1995; 127: 220-224
- Characteristics and outcomes of pediatric cholestasis in alagille syndrome in the modern era: results of a multi-centre prospective observational study.Hepatology. 2017; 66 ([abstract]): 60A
- Paucity of interlobular bile ducts. Arteriohepatic dysplasia and nonsyndromic duct paucity.Perspect Pediatr Pathol. 1991; 14: 168-215
- Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome.Circulation. 2002; 106: 2567-2574
- The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome.Hum Mol Genet. 1999; 8: 2443-2449
- Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality.Circulation. 2004; 109: 1354-1358
- Bleeding tendency in children with Alagille syndrome.Pediatrics. 2003; 111: 167-170
- Alagille syndrome associated with angiographic moyamoya.Childs Nerv Syst. 2002; 18: 186-190
- Intracranial vascular abnormalities in patients with Alagille syndrome.J Pediatr Gastroenterol Nutr. 2005; 41: 99-107
- Spectrum of cerebral arterial and venous abnormalities in Alagille syndrome.Pediatr Radiol. 2018; https://doi.org/10.1007/s00247-017-4043-2
- JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype.J Med Genet. 2000; 37: 658-662
- Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases.J Pediatr. 1987; 110: 195-200
- Renal anomalies in Alagille syndrome: a disease-defining feature.Am J Med Genet A. 2012; 158A: 85-89
- Vertebral anomalies in children with Alagille syndrome: an analysis of 50 consecutive patients.Pediatr Radiol. 2002; 32: 114-119
- Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood.J Pediatr Gastroenterol Nutr. 1987; 6: 865-871
- Variable morbidity in alagille syndrome: a review of 43 cases.J Pediatr Gastroenterol Nutr. 1999; 29: 431-437
- Facial features in Alagille syndrome: specific or cholestasis facies?.Am J Med Genet. 2002; 112: 163-170
- Syndrome of Alagille: radiological and sonographic findings. A review of 37 cases.Eur Radiol. 1997; 7: 115-118
- Temporal bone histopathologic findings in Alagille's syndrome.Arch Otolaryngol Head Neck Surg. 1990; 116: 217-220
- Deficits in size-adjusted bone mass in children with Alagille syndrome.J Pediatr Gastroenterol Nutr. 2005; 40: 76-82
- Pathologic lower extremity fractures in children with Alagille syndrome.J Pediatr Gastroenterol Nutr. 2010; 51: 66-70
- Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies.Am J Hum Genet. 2010; 86: 229-239
- Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.Bone. 2016; 91: 64-74
- Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients.Hum Mol Genet. 2012; 21: 1374-1383
- The prevalence and associated features of posterior embryotoxon in the general ophthalmic clinic.Eye (Lond). 2005; 19: 396-399
- Ocular ultrasound in Alagille syndrome: a new sign.Ophthalmology. 1997; 104: 79-85
- Ocular abnormalities in Alagille syndrome.Ophthalmology. 1999; 106: 330-337
- The genetics and ocular findings of Alagille syndrome.Semin Ophthalmol. 2007; 22: 205-210
- Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea.J Pediatr Gastroenterol Nutr. 2002; 35: 495-502
- Anthropometric evaluation of children with chronic liver disease.Am J Clin Nutr. 1990; 52: 203-208
- Growth is not related to the presence of vertebral anomalies in alagille syndrome.J Pediatr Gastroenterol Nutr. 1998; 27 ([abstract]): 469
- Exocrine pancreatic insufficiency in syndromic paucity of interlobular bile ducts.J Pediatr Gastroenterol Nutr. 1989; 9: 445-449
- Pancreatic insufficiency is not a prevalent problem in Alagille syndrome.J Pediatr Gastroenterol Nutr. 2012; 55: 612-614
- Exocrine pancreatic function in children with Alagille syndrome.Sci Rep. 2016; 6: 35229
- Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur.J Pediatr. 1975; 86: 63-71
- Health status of patients with Alagille syndrome.J Pediatr Gastroenterol Nutr. 2010; 51: 759-765
- Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience.Liver Transpl. 2012; 18: 940-948
- Neurocognitive status in alagille syndrome: results of a mult-center prospective observational study.Hepatology. 2017; 66 ([abstract]): 647A
- Learning and memory deficits in Notch mutant mice.Curr Biol. 2003; 13: 1348-1354
- Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome.Gastroenterology. 1999; 116: 1141-1148
- Alagille syndrome.J Med Genet. 1997; 34: 152-157
- Alagille syndrome.in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews((R)). University of Washington, Seattle, Seattle (WA)2013
- Notch signalling in context.Nat Rev Mol Cell Biol. 2016; 17: 722-735
- Jagged1 (JAG1): structure, expression, and disease associations.Gene. 2016; 576: 381-384
- Notch signaling in human development and disease.Semin Cell Dev Biol. 2012; 23: 450-457
- The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies.Hum Genet. 2017; 136: 665-677
- Jagged: a mammalian ligand that activates Notch1.Cell. 1995; 80: 909-917
- Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate.Hum Mutat. 2006; 27: 436-443
- A mouse model of Alagille syndrome: notch2 as a genetic modifier of Jag1 haploinsufficiency.Development. 2002; 129: 1075-1082
- Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology.J Hepatol. 2014; 61: 1056-1063
- Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H).Curr Biol. 1995; 5: 1416-1423
- Segregation analysis of Alagille syndrome.J Med Genet. 1994; 31: 453-457
- Alagille syndrome: family studies.J Med Genet. 1995; 32: 264-268
- Discordant clinical phenotype in monozygotic twins with Alagille syndrome: possible influence of non-genetic factors.Am J Med Genet A. 2016; 170A: 471-475
- Arteriohepatic dysplasia (Alagille syndrome): extreme variability among affected family members.Am J Med Genet. 1984; 19: 325-332
- Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.Am J Hum Genet. 1998; 62: 1361-1369
- Jagged1 mutations in alagille syndrome.Hum Mutat. 2001; 17: 18-33
- Early life predictive markers of liver disease outcome in an International, Multicentre cohort of children with Alagille syndrome.Liver Int. 2016; 36: 755-760
- Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.Hum Mutat. 2010; 31: 594-601
- Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.Am J Hum Genet. 2003; 72: 1065-1070
- Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome.Hum Mol Genet. 2001; 10: 405-413
- Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi.Development. 2011; 138: 1925-1934
- Role of glycans and glycosyltransferases in the regulation of Notch signaling.Glycobiology. 2010; 20: 931-949
- Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.Hepatology. 2008; 48: 1989-1997
- O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking.J Biol Chem. 2017; 292: 15964-15973
- Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi).Hepatology. 2016; 63: 550-565
- THBS2 is a candidate modifier of liver disease severity in alagille syndrome.Cell Mol Gastroenterol Hepatol. 2016; 2: 663-675 e2
- Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease.J Pediatr Gastroenterol Nutr. 1998; 26: 49-55
- Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children.J Pediatr Gastroenterol Nutr. 2010; 51: 787-789
- Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome.Hepatology. 2002; 35: 1501-1506
- Relief of intractable pruritus in Alagille syndrome by partial external biliary diversion.J Pediatr Surg. 2006; 41 ([discussion: 104–7]): 104-107
- Ileal exclusion for refractory symptomatic cholestasis in Alagille syndrome.J Pediatr Surg. 2007; 42: 800-805
- Results of ITCH, A multicenter randomized double-blind placebo-controlled trial of maralixibat, an ileal apical sodium-dependent bile acid transporter inhibitor (ASBTi), for pruritus in alagille syndrome (ALGS).Hepatology. 2017; 66 ([abstract]): 84A
- Alagille syndrome and liver transplantation.J Pediatr Gastroenterol Nutr. 2010; 50: 11-15
- Living-related liver transplantation for Alagille syndrome.Transplantation. 2003; 75: 2147-2150
- Therapeutic modulation of Notch signalling–are we there yet?.Nat Rev Drug Discov. 2014; 13: 357-378
- Therapeutics based on stop codon readthrough.Annu Rev Genomics Hum Genet. 2014; 15: 371-394
- Concise review: updated advances and current challenges in cell therapy for inborn liver metabolic defects.Stem Cells Transl Med. 2016; 5: 1117-1125
- Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids.Nat Med. 2017; 23: 954-963
- Cholangiocytes derived from induced pluripotent stem cells for disease modeling.Curr Opin Gastroenterol. 2016; 32: 210-215
- The notch ligand jagged1 regulates the osteoblastic lineage by maintaining the osteoprogenitor pool.J Bone Miner Res. 2017; 32: 1320-1331
- Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing.PLoS One. 2013; 8: e68726
- Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects.NPJ Regen Med. 2017; 2: 32
Article info
Publication history
Published online: August 22, 2018
Footnotes
Disclosure Statement: No disclosures to report.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
